Longitudinal assessment of peripheral blood BRAFV600E levels in patients with Langerhans cell histiocytosis (Q93360995)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30474648 AND SRC:MED&resulttype=core&format=json

5 May 2020

title

Longitudinal assessment of peripheral blood BRAFV600E levels in patients with Langerhans cell histiocytosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30474648 AND SRC:MED&resulttype=core&format=json

Langerhans cell histiocytosis specific to childhood

5 May 2020

main subject

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30474648 AND SRC:MED&resulttype=core&format=json

5 May 2020

author name string

Raphaela Schwentner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30474648 AND SRC:MED&resulttype=core&format=json

5 May 2020

Alexandra Kolenová

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30474648 AND SRC:MED&resulttype=core&format=json

5 May 2020

Gunhild Jug

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30474648 AND SRC:MED&resulttype=core&format=json

5 May 2020

Thomas Schnöller

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30474648 AND SRC:MED&resulttype=core&format=json

5 May 2020

Martina Ahlmann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30474648 AND SRC:MED&resulttype=core&format=json

5 May 2020

Bernhard Meister

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30474648 AND SRC:MED&resulttype=core&format=json

5 May 2020

Thomas Lehrnbecher

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30474648 AND SRC:MED&resulttype=core&format=json

5 May 2020

Milen Minkov

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30474648 AND SRC:MED&resulttype=core&format=json

5 May 2020

publication date

24 November 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30474648 AND SRC:MED&resulttype=core&format=json

5 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30474648 AND SRC:MED&resulttype=core&format=json

5 May 2020

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30474648 AND SRC:MED&resulttype=core&format=json

5 May 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30474648 AND SRC:MED&resulttype=core&format=json

5 May 2020

page(s)

856-864

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30474648 AND SRC:MED&resulttype=core&format=json

Histiocytoses: emerging neoplasia behind inflammation

5 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

Recurrent BRAF mutations in Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

Histiocytic neoplasms in the era of personalized genomic medicine

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

Targeted inhibition of the MAPK pathway: emerging salvage option for progressive life-threatening multisystem LCH

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA.

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

Comparison of molecular testing methods for the detection of EGFR mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

Integrating liquid biopsies into the management of cancer

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults.

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

Circulating cell-free BRAFV600E as a biomarker in children with Langerhans cell histiocytosis.

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

The BRAF-V600E mutation in circulating cell-free DNA is a promising biomarker of high-risk adult Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

Peripheral blood late mixed chimerism in leucocyte subpopulations following allogeneic stem cell transplantation for childhood malignancies: does it matter?

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

Droplet Digital PCR versus qPCR for gene expression analysis with low abundant targets: from variable nonsense to publication quality data

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

Vemurafenib in Langerhans cell histiocytosis: report of a pediatric patient and review of the literature.

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

CD1c blood dendritic cells have Langerhans cell potential.

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

JAG2 signaling induces differentiation of CD14 monocytes into Langerhans cell histiocytosis-like cells

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

Langerhans-Cell Histiocytosis

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

Cell-free nucleic acids as biomarkers in cancer patients

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

Genetic profiling of tumours using both circulating free DNA and circulating tumour cells isolated from the same preserved whole blood sample.

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

Effects of blood-processing protocols on cell-free DNA quantification in plasma

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: In memory of Bob Arceci

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

Is Langerhans cell histiocytosis a neoplasia?

1 reference

https://api.crossref.org/works/10.1038/S41390-018-0238-Y

7 January 2021

10.1038/S41390-018-0238-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30474648 AND SRC:MED&resulttype=core&format=json

5 May 2020

1 reference